Fundz

Resolys Bio, Inc. reported raising $200,000 in an amended SEC Form D filing, from an offering of $6 Million

PRIVATESep 25, 2017$200K of $6M raised

Amount Raised

$200,000

$200,000 sold, per SEC Form D (first sale Sep 25, 2017)

Round Type

Pre-Seed

DelansonBiotechnology

Quick answer

Resolys Bio raised $200,000 in a Pre-Seed round, dated September 25, 2017. Resolys Bio is based in Delanson, New York, United States.

How much did Resolys Bio raise?
Resolys Bio raised $200,000 in a Pre-Seed round on September 25, 2017.
What does Resolys Bio do?
Headquartered in Delanson, NY, Resolys Bio, Inc., a Delaware Corporation, (“Resolys” or the “Company”) is a privately held pharmaceutical Company formed in 2016 by Beech Tree Labs, Inc. (“Beech Tree Labs”) to..
Where is Resolys Bio based and how big is it?
Resolys Bio is based in Delanson, New York, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Resolys Bio that raised within 45 days of this round, from Fundz verified event records.

  • Emulate, Inc. raised $746K (Seed) on November 9, 2017.
  • Anthera Pharmaceuticals Inc raised $2.9M (Seed) on November 9, 2017.
  • PROGENITY, INC. raised $50M on November 9, 2017.
  • Soligenix raised $2M (Seed) on November 8, 2017.
  • Phreesia raised $17M on November 8, 2017.
  • Opsonix, Inc. raised $1M (Seed) on November 8, 2017.

Who to call at Resolys Bio, and when

A new round usually means Resolys Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Resolys Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Resolys Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Resolys Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Resolys Bio

Location

545 WESTFALL ROAD

Delanson, New York, United States

About

Headquartered in Delanson, NY, Resolys Bio, Inc., a Delaware Corporation, (“Resolys” or the “Company”) is a privately held pharmaceutical Company formed in 2016 by Beech Tree Labs, Inc. (“Beech Tree Labs”) to commercialize two pharmaceutical products that it developed– oxidized streptolysin O (“oSLO”) and a proprietary multi-component compound (“MCC”). These products utilize cellular signaling to impact several medical conditions. oSLO modulates, and in some cases reverses, the symptoms associated with chronic traumatic brain injury (“cTBI”). MCC can ameliorate pain and fatigue of patients with a form of joint hypermobility called hypermobile Ehlers Danlos Syndrome (“hEDS”) The Company’s leadership includes a number of current and former biotech CEOs and embodies over 150 years of combined experience in building successful enterprises.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Resolys Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Resolys Bio's next move

See what Strategic adds

Resolys Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.